Shareholders might have noticed that Inspire Medical Systems, Inc. ( NYSE:INSP ) filed its yearly result this time ...

Inspire Medical Systems (NYSE:INSP – Get Free Report) had its price objective lowered by Truist Financial from $250.00 to $235.00 in a note issued to investors on Tuesday,Benzinga reports. The ...

Inspire Medical Systems, Inc. (NYSE:INSP – Get Free Report) gapped down before the market opened on Tuesday after Truist Financial lowered their price target on the stock from $250.00 to $235.00. The ...

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

Inspire Medical Systems, Inc. INSP delivered an earnings per share (EPS) of $1.15 in fourth-quarter 2024, up 134.7% from the ...

In a highly anticipated conference call, Inspire Medical Systems reported an impressive fourth quarter and full year 2024 ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inspire Medical Systems (INSP – Research ...

Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...

Revenue for Q4 2024 was $239.7 million, marking a 25% year-over-year increase. Net income reached $35.2 million compared to $14.8 million in Q4 2023. Herbert reiterated the 2025 revenue guidance of ...

Inspire Medical Systems ( INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...